Michael Minogue's commanding lead in the Massachusetts Republican primary stems primarily from securing the party endorsement at the state convention in April 2026, which consolidated support after Mike Kennealy withdrew and backed him. As a political newcomer with substantial personal resources and executive experience as former Abiomed CEO, Minogue has maintained broad backing among delegates and donors ahead of the September 1 primary. Brian Shortsleeve, a former MBTA official, and the limited remaining field have shown minimal traction in recent positioning. With probabilities exceeding 90 percent, the outcome remains sensitive to late developments such as unexpected turnout shifts or health-related issues, though structural advantages make such reversals unlikely before voting concludes.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於麥可·米諾格 95.4%
布賴恩·肖特斯利夫 1.4%
Mike Kennealy <1%
$29,248 交易量
$29,248 交易量

麥可·米諾格
95%

布賴恩·肖特斯利夫
1%

Mike Kennealy
<1%
麥可·米諾格 95.4%
布賴恩·肖特斯利夫 1.4%
Mike Kennealy <1%
$29,248 交易量
$29,248 交易量

麥可·米諾格
95%

布賴恩·肖特斯利夫
1%

Mike Kennealy
<1%
If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
市場開放時間: Dec 10, 2025, 4:20 PM ET
Resolver
0x2F5e3684c...If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
Resolver
0x2F5e3684c...Michael Minogue's commanding lead in the Massachusetts Republican primary stems primarily from securing the party endorsement at the state convention in April 2026, which consolidated support after Mike Kennealy withdrew and backed him. As a political newcomer with substantial personal resources and executive experience as former Abiomed CEO, Minogue has maintained broad backing among delegates and donors ahead of the September 1 primary. Brian Shortsleeve, a former MBTA official, and the limited remaining field have shown minimal traction in recent positioning. With probabilities exceeding 90 percent, the outcome remains sensitive to late developments such as unexpected turnout shifts or health-related issues, though structural advantages make such reversals unlikely before voting concludes.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於



警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions